The Supreme Court dismissed a PIL challenging aspects of India's HPV vaccination programme for adolescent girls after the petitioner raised concerns over informed parental consent and monitoring of adverse events.
The petitioner said it was not opposing the vaccine itself, but questioning implementation safeguards. The bench noted the strong public-health backing for HPV vaccination and allowed the petitioner to withdraw the plea.
The policy issue is broader than one vaccine: public-health programmes must combine scientific evidence with transparent consent, surveillance of adverse events and credible risk communication. Weak communication can reduce trust even when the underlying intervention is evidence-based.